Nalbuphine as an Adjuvant to Local Anaesthetic Mixture in Peribulbar Cataract Surgery

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

January 14, 2018

Primary Completion Date

February 20, 2018

Study Completion Date

February 28, 2018

Conditions
Nalbuphine as an Adjuvant to L. A in Peribulbar Block for Cataract Surgery
Interventions
DRUG

Nalbuphine

"Both groups received 8 ml solution for the peribulbar block, Patients of group N was received a mixture of 3 ml of 2% lidocaine, 4 ml of 0.5% bupivacaine with hyaluronidase (75IU)(16) and 4mg of nalbuphine in 1 ml normal saline. Patients of group C was received a mixture of 3 ml of 2% lidocaine, 4 ml of 0.5% bupivacaine with hyaluronidase (75 IU) and 1 ml normal saline. Nalbuphine (20mg amp.) was prepared in 0.9% sodium chloride in 5mL syringe.~If the block was inadequate after 10 minutes, a 2-4 ml supplementation of local anesthetics was given by the same technique and the patient was excluded from the study.~After adequate analgesia (loss of sensation to touch by a small cotton wool) and akinesia, the surgeon was allowed to start the surgery"

DRUG

lidocaine, bupivacaine, hyaluronidase , saline

lidocaine, 0.5% bupivacaine, 1 ml hyaluronidase (75 IU) and 1 ml saline (total 8 ml).

DRUG

lidocaine, bupivacaine , hyaluronidase

2% lidocaine, 4 ml of 0.5% bupivacaine with hyaluronidase (75IU)

Trial Locations (2)

11451

Ahmed Abdalla Mohamed, Cairo

Ahmed Abdalla, Cairo

All Listed Sponsors
collaborator

Mohamed, Ahmed A., M.D.

INDIV

collaborator

Nadia Yossif Helmy

UNKNOWN

collaborator

Ahmed Elbadawy Mahmoud

UNKNOWN

collaborator

Abdelhamid, Bassant Mohamed, M.D.

INDIV

collaborator

Atef Kamel Salama

UNKNOWN

collaborator

Mostafa Abdalwahab Elberry

UNKNOWN

lead

Cairo University

OTHER

NCT03436836 - Nalbuphine as an Adjuvant to Local Anaesthetic Mixture in Peribulbar Cataract Surgery | Biotech Hunter | Biotech Hunter